Item no. |
HY-W017770-500mg |
Manufacturer |
MedChem Express
|
CASRN |
97540-22-2 |
Amount |
500 mg |
Quantity options |
100 mg
10 mM/1 mL
250 mg
500 mg
50 mg
|
Category |
|
Type |
Inhibitors |
Specific against |
other |
Purity |
98.80 |
Formula |
C22H34N6O16S4 |
Citations |
Pharmacol Res. 2024 Sep 16:107420. Biochem Pharmacol. 2023 Dec 6:219:115967. bioRxiv. 2023 Jun 1. Epigenetics Chromatin. 2021 Dec 4;14(1):52. Int Immunopharmacol. 2021 Mar 22;95:107545. J Agric Food Chem. 2021 Jul 30. Research Square Preprint. 2020 Aug. Research Square Preprint. 2021 Jun. J Cell Physiol. 2024 Oct 6:e31452. Molecules. 2023 Apr 11, 28(8), 3375. J Pharm Biomed Anal. 2024 Jan 20, 115991. [1]Lu SC, et al. S-adenosylmethionine in liver health, injury, and cancer. Physiol Rev. 2012 Oct;92(4):1515-42. [2]Bressa GM. S-adenosyl-l-methionine (SAMe) as antidepressant: meta-analysis of clinical studies. Acta Neurol Scand Suppl. 1994;154:7-14. [3]Najm WI, et al. S-adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: a double-blind cross-over trial. [ISRCTN36233495]. BMC Musculoskelet Disord. 2004 Feb 26;5:6. [4]Mosca L, et al. Effects of S‑adenosyl‑L‑methionine on the invasion and migration of head and neck squamous cancer cells and analysis of the underlying mechanisms. Int J Oncol. 2020 May;56(5):1212-1224. [5]Ham MS, et al. S-adenosyl methionine specifically protects the anticancer effect of 5-FU via DNMTs expression in human A549 lung cancer cells. Mol Clin Oncol. 2013 Mar;1(2):373-378. [6]Ornoy A, et al. S-adenosyl methionine prevents ASD like behaviors triggered by early postnatal valproic acid exposure in very young mice. Neurotoxicol Teratol. 2019 Jan-Feb;71:64-74. [7]Dhediya RM, et al. Evaluation of antiepileptic effect of S-adenosyl methionine and its role in memory impairment in pentylenetetrazole-induced kindling model in rats. Epilepsy Behav. 2016 Aug;61:153-157. |
Smiles |
N[C@@H](CC[S+](C[C@@H]1[C@H]([C@H]([C@H](N2C=NC3=C2N=CN=C3N)O1)O)O)C)C(O)=O.O=S(O)([O-])=O.O=S(O)(O)=O.OS(=O)(C4=CC=C(C)C=C4)=O |
ECLASS 10.1 |
32160490 |
ECLASS 11.0 |
32160490 |
UNSPSC |
12000000 |
Alias |
Ademetionine (disulfate tosylate), S-Adenosyl methionine (disulfate tosylate), AdoMet (disulfate tosylate) |
Shipping condition |
Cool pack |
Available |
|
Manufacturer - Type |
Natural Products |
Manufacturer - Applications |
Neuroscience-Neuromodulation |
Manufacturer - Targets |
Apoptosis; Endogenous Metabolite |
Shipping Temperature |
Blue Ice |
Storage Conditions |
-20°C (Powder, sealed storage, away from moisture) |
Molecular Weight |
766.80 |
Product Description |
S-Adenosyl-L-methionine disulfate tosylate is the disulfate tosylate form of S-Adenosyl-L-methionine (HY-B0617). S-Adenosyl-L-methionine is an orally active methyl group donor. S-Adenosyl-L-methionine is a dietary supplement with potent antidepressant effects. S-Adenosyl-L-methionine also has anti‑proliferative, pro‑apoptotic and anti‑metastatic roles in cancers. S-Adenosyl-L-methionine has the potential for, cancer, liver disease and osteoarthritis research[1][2][3]. |
Manufacturer - Research Area |
Neurological Disease; Cancer |
Solubility |
DMSO : ≥ 50 mg/mL|H2O : 33.33 mg/mL (ultrasonic) |
Manufacturer - Pathway |
Apoptosis; Metabolic Enzyme/Protease |
Isoform |
Human Endogenous Metabolite |
Clinical information |
Launched |
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.